Home › Occupations › Natural Sciences Managers › St. Louis, MO
Natural Sciences Managers in St. Louis, MO: H-1B salaries
32 labor condition applications for this occupation with a work site in St. Louis, MO. Median offered base salary $62,941; middle half $60,715–$65,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $61,650 |
| Level II (qualified) | $82,000 |
| Level III (experienced) | $150,000 |
| Level IV (fully competent) | $165,600 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Washington University | 23 | $62,500 |
| Bayer CropScience LP | 2 | $146,665 |
| Saint Louis University | 1 | $53,726 |
| Vir Biotechnology, Inc. | 1 | $165,600 |
| PsychCare Consultants Research | 1 | $60,800 |
| Jost Chemical Company | 1 | $191,174 |
| Amicis Clinical Trials LLC | 1 | $62,629 |
| Donald Danforth Plant Science Center | 1 | $82,000 |
| Missouri Botanical Garden | 1 | — |
Job titles
- Clinical Research Coordinator II9
- Clinical Research Coordinator I8
- Clinical Research Coordinator2
- Public Health Research Coordinator II2
- Global ES/VS Field Force Data and Analytics Lead1
- Sr Manager, Laboratory Operations1
- Clinical Research Associate1
- VS PS Digital Strategy Lead - Field & Processing1
- Director of Quality and Regulatory1
- Clinical Trial Coordinator1
- Senior Clinical Research Coordinator1
- Research Associate II1
- Senior Vice President, Biodiversity Research1
- Clinical Research Coordinator 11
- Pulic Health Research Coordinator II1
H-1B sponsors in St. Louis, MO →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).